Monday, September 14, 2026

JPi Healthcare’s DRE Duo: FDA Approval Opens Doors to the U.S. Market

JPi Healthcare launches its DRE Duo digital X-ray system in the U.S., enhancing global expansion and targeting international markets.

North Korea FINALLY Gets X-Ray Tech—After DECADES Of Human Rights Misery

Kim Jong Un plans to open four new hospitals in North Korea, highlighting a push for healthcare infrastructure despite equipment concerns.

AI Optimists vs. Pessimists: Who Will Control the Future?

By the 2030s, eight of ten consumers...

Tag: Dupixent

North KoreaKoreaKimMilitaryAISouth Koreamarketrelationsdevelopment

GI Innovation Uses AI to Develop Next-Gen Allergy Drug Aimed at Dupixent’s $15 Billion Market

GI Innovation is advancing an AI-optimized allergy treatment, targeting multiple pathways in atopic dermatitis to rival Dupixent.

Chong Kun Dang Wins European Phase 1 Approval for Dupixent Biosimilar: Advancing CKD-706’s Global Development

Chong Kun Dang's CKD-706 biosimilar for Dupixent received Phase 1 trial approval in Europe, aiming to expand treatment options for inflammatory diseases.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.